Increased activation of Akt signaling pathway could play a pivotal role in acceleration of growth of xenograft of miR-21-overexpressing colon cancer cells in SCID mice, that we reported earlier [12] and could confer drug resistance to different malignancies including colorectal cancer [5], [6], [7], [8]. This evidence concerns the gene AKT1 and colorectal cancer.